๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Neuroprotectants for Parkinson's disease reviewed

Book ID
120859252
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2003
Weight
140 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Neuroprotection trials in Parkinson's di
Neuroprotection trials in Parkinson's disease: Systematic review
โœ Robert G. Hart; Lesly A. Pearce; Bernard M. Ravina; Toby C. Yaltho; John R. Marl ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB

## Abstract Treatments to slow the progression are a major unmet need in Parkinson's disease. Detailed assessment of randomized trials testing putative neuroprotective drugs was undertaken to inform the design, reporting, and interpretation of future studies. This study is a systematic review of tr

Neuroprotective Therapy for Parkinson's
Neuroprotective Therapy for Parkinson's disease
โœ I.Shoulson and the Parkinson Study Group ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 103 KB ๐Ÿ‘ 1 views

In the context of degenerative disorders of the basal ganglia, neuroprotective therapy refers to interventions that preserve the integrity and function of vulnerable neurons and thereby slow or halt clinical decline. Decoppering therapy for Wilson's disease is the only established neuroprotective th